AKTS — Aktis Oncology, Inc.
Median target
$34
calls from the last 12 months
Implied return
+48.7%
median target vs. price
Coverage
6 analysts · 6 calls
updated in the last 12 months
Consensus
6/0/0+6 net
Buy / Hold / Sell
Which analysts are behind AKTS's consensus?
See every current rating, price target and the analysts' track records for Aktis Oncology, Inc. — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 6 analysts with calls on AKTS updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.